---
permalink: /
title: "About me"
excerpt: "About me"
author_profile: true
redirect_from: 
  - /about/
  - /about.html
---

Hi, Iâ€™m Shivaprasad Patil, Associate Director of Bioinformatics â€“ Predictive AI, with a deep passion for transforming drug discovery and precision medicine through the power of data and AI. With over a decade of experience, I specialize in leveraging clinical and genomics data using advanced machine learning and computational biology techniques.

My core expertise lies in multi-omics data integration across diverse platforms â€” including bulk, single-cell, and spatial genomics; imaging modalities like Cell Painting and immunofluorescence; and clinical datasets such as EHRs, disease registries, and IHC. I thrive in collaborative, cross-functional environments, driving biomarker discovery and translational insights that push therapeutics forward through the development pipeline.


Featured Projects
======

### [BulkRNA-Agent: AI-Powered Transcriptomics Analysis](https://github.com/shivaprasad-patil/BulkRNA-Agent)
Open-source AI tool combining dual LLM architecture (reasoning + biomedical models) for intelligent bulk RNA-seq analysis. Features AI-powered design suggestions, interactive visualizations, and 100% local processing for data privacy. Streamlines the entire pipeline from QC to differential expression and enrichment analysis in one intuitive web interface.

### [ScAdver: Adversarial Batch Correction for Single-Cell Data](https://github.com/shivaprasad-patil/ScAdver)
Python package that performs adversarial batch correction for single-cell RNA-seq data, eliminating technical batch effects while preserving biological variation and cell type identity. The framework features a train-once, project-forever paradigmâ€”train on reference data, then rapidly transform unlimited query batches without retraining. For challenging scenarios with large protocol shifts (e.g., 10X â†’ Smart-seq2), advanced domain adaptation via residual adapters enables robust cross-technology integration while maintaining biological fidelity.

### [MultiOmicsBind: Deep Learning for Multi-Omics Integration](https://github.com/shivaprasad-patil/MultiOmicsBind)
Deep learning framework that brings ImageBind's revolutionary binding modality concept to multi-omics data integration. Enables seamless integration of genomics, transcriptomics, proteomics, and metabolomics data for comprehensive biological insights.

[**View all projects â†’**](/projects/)

---

Experience
======

Associate Director Bioinformatics & Predictive AI: AstraZeneca
------
ğŸ¤– Implementing new predictive capabilities using AI and bioinformatics to translate omics and imaging data into discoveries of novel mechanisms of action for compounds.

ğŸ§¬ğŸ’» Building in silico pipelines to advance multi-omics technologies (bulk & spatial) for refining toxicity predictions and accelerating candidate drug prioritization.

ğŸ§ ğŸ–¼ï¸ Developing AI models to extract predictive morphological features from Cell Painting, delivering detailed and cost-effective safety insights.

ğŸ§ªğŸ“Š Building proteomics-driven models to gain deep mechanistic insights and improve compound selection in early drug discovery.


Scientific Investigator - Computational Biology: GSK
------
ğŸ”¬ Analyzing and Integrating Multi-Omics Data: Proficient in the analysis and integration of multi-omics data, including single-cell level analyses, to uncover intricate biological insights.

ğŸ“Š Clinical Trial Data Expertise: Experienced in conducting post-hoc analyses of data from clinical trials, driving the exploration of new precision medicine approaches and facilitating biological discoveries.

ğŸ§  Translational iPSC Model for Alzheimerâ€™s Disease: Unraveling the Molecular Maze.
 - Multi-omics dataâ€”genomics, transcriptomics, proteomics, phospho-proteomics, lipidomics, â€”harmonize to reveal the genetic and molecular symphony of Alzheimerâ€™s. ğŸµğŸ”
 - Target Identification: Seeking the elusive targetsâ€”the molecular keys that unlock Alzheimerâ€™s mysteries. By integrating multi-omics data, to pinpoint molecular subtypes, predict disease progression, and tailor personalized treatments. ğŸ¯ğŸ’¡


ğŸ§¬ Genomics Data Analysis: Adept at harnessing genomics data for reverse translation, enabling patient stratification, and guiding targeted therapies.

ğŸš€ Translational Signature Development: Skilled in identifying and developing translational signatures that enhance indication expansion and model translatability, fostering advancements in drug development.

Bioinformatician / ML Research Scientist: OncoRay - Center for Radiation Research in Oncology
------
ğŸ”¬ Collaborated with multicenter, multidisciplinary teams to predict patient prognosis in Head and Neck Squamous Cell Carcinoma, spanning 8 cohorts and involving 1500 patients.

ğŸ“Š Applied advanced statistical and machine learning techniques to genomics and clinical data, leading to the identification of three groundbreaking biomarkers for personalized radiation oncology.

ğŸ¯ Leveraged biomarkers to facilitate patient selection for enhanced individualized treatment options in prospective clinical trials, partnering with over 30 clinicians and experimental scientists.

ğŸ™ï¸ Delivered more than 50 poster and oral presentations, sharing insights and discoveries with the scientific community.

ğŸ“š Contributed as a reviewer to the esteemed "Radiotherapy & Oncology" journal, fostering knowledge exchange and scientific advancement.

<br/><img src='/files/Biomarker_Pitch.png'>

Bioinformatician
------
ğŸ§¬ Pioneered the creation of an innovative pipeline for the analysis of viral metagenomic data, pushing the boundaries of bioinformatics.

ğŸ” Assembled an extensive catalog of 3000 viral genes and proteins, contributing to the advancement of viral genomics research.

ğŸ¥ Successfully identified critical biomarkers for the early diagnosis of liver fibrosis in a cohort of 200 patients, facilitating early intervention and patient care.


Bioinformatician
------
ğŸŒ€ Discovered and annotated an impressive portfolio of over 60,000 novel Circular RNAs, unraveling new dimensions of genomic research.

ğŸ¤ Collaborated extensively with a network of 280 clinicians and researchers spanning over 60 medical and research centers, leveraging Exome-Sequencing for an in-depth exploration of Rare Genetic Diseases through variant prioritization and calling.

ğŸ§¬ Explored the intricate role of Non-coding RNAs in gene regulation, drawing insights from a diverse array of 38 datasets, contributing to our understanding of genomic complexity.
<br/><img src='/files/Exome_seq.jpeg'>

Education
======
Doctor of Philosophy - PhD, Biostatistics and Biomedicine: Technische UniversitÃ¤t Dresden, Germany, 2019-2022.

Integrated BS-Â­MS in Life Â­Sciences: Indian Institute of Science Education and Research Mohali, India 2010-2015.
